Dr. Satyajeet Soni is presently working as Assistant Professor, Department of Medical Oncology at the Sri Ram Cancer Center of the Mahatma Gandhi Medical College and Hospital, Jaipur. He has completed his post-graduation MD Internal medicine from the SMS Medical College and completed his super speciality training DrNB Medical Oncology from Rajiv Gandhi Cancer Institute and Research Center, New Delhi. He has special interest in treatment of Breast cancer, Lung cancer, Gynaecological, Hepatobiliary, Gastrointestinal cancers, Lymphoma and Multiple Myeloma. During his oncology training at RGCIRC he was awarded with best resident award in 2022.
-
-
-
-
Best Resident Award 2022, RGCIRC, New Delhi
-
ESMO Examination Certificate (ECMO), September 2022
-
Member for European Society of Medical Oncology (ESMO)(ESMO ID 506067)
-
Biomarker testing in non-small cell lung carcinoma–More is better: A case series (Cancer Research, Statistics, and Treatment. 2020)
-
330P COVID and cancer: Choosing between hammer and anvil. (Annals of Oncology, November 2020)
-
Miliary Brain Metastasis—A Rare Pattern of Metastases from Breast Cancer (South Asian Journal of Cancer. 2020)
-
Chronic Myeloid Leukemia (CML) in Adolescents & Young Adults (AYA): Single Institution 10 Years Experience with 1st Line Imatinib Mesylate (IM) (Blood. 2020)
-
Identification of a novel ALK variant intrinsically resistant to crizotinib (Current Problems in Cancer: Case Reports. 2020)
-
P40.04 Knowledge, Attitudes and Perception of Lung Cancer Screening Among Smoking Soft-Ware Professionals in India. (Journal of thoracic oncology, March 2021)
-
Are all ALK variants created equal? Clinicopathologic features and outcomes: a propensity-matched study (International Journal of Clinical Oncology. 2021)
-
Spectrum of BRAF mutations in Indian patients with NSCLC: A molecular kaleidoscope. (JCO-ASCO 2021)
-
Hyper-Progressive Disease (HPD) during Immune Checkpoint Inhibitor (ICI) Therapy. (IJMPO. 2022)
-
Serpentine Supra-venous Hyperpigmentation “Badge of Courage’’ in Fight Against Cancer: An Brief Review (Gulf Journal of Oncology, September 2022)
-
P-21 Molecular subtypes (profile) of colorectal cancer and their correlation with clinical and pathological profile in a tertiary care centre in India. (Annals of Oncology, June 2022)
-
Co-relation of SARS-CoV-2 related 30-d mortality with HRCT score and RT-PCR Ct value-based viral load in patients with solid malignancy (World Journal of Clinical Oncology. 2022)
-
Unveiling the uncommon: Disseminated intravascular coagulation as an unusual presentation of metastatic carcinoma prostate (IP Archives of Cytology and Histopathology Research, 2023)
-
Outcome in patients with multiple myeloma: Does age matter? (Editorial, Cancer Research, Statistics, and Treatment, 2023)
-
Genetic counselling for hereditary cancers: Not everybody’s cup of tea! (Letter to editor, Cancer Research, Statistics, and Treatment, 2023)
-
Epidemiological factors and survival among patients of stroke (RAJAPICON – 2017)
-
Varied treatment responses in hemolytic anemia (RAJAPICON – 2017)
-
Etiological spectrum of severe anemia (RAJAPICON – 2017)
-
Weston’s Hurst disease variant of ADEM – Rare presentation of Dengue fever (APICON -2018)
-
Rare coagulation disorder – Factor XI and XII deficiency with large spontaneous hematoma (APICON – 2018)
-
Spectrum of BRAF mutations in Indian patients with NSCLC: A molecular kaleidoscope (ASCO – 2021)
-
Longitudinal observational study of the role of HPV in Head and Neck Cancer (during MD Internal Medicine)
-
Prospective observational study of efficacy and toxicity of mFOLFIRINOX chemotherapy regimen in locally advanced unresectable and metastatic Ca Pancreas (during DrNB Medical Oncology)